Litcius/Paper detail

Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies

Melissa L. Johnson, Marina Chiara Garassino, Tony Mok, Tetsuya Mitsudomi

2022Lung Cancer150 citationsDOI

Topics & Concepts

AfatinibGefitinibMedicineErlotinibOsimertinibLung cancerEpidermal growth factor receptorTyrosine kinaseT790MOncologyEGFR inhibitorsCancer researchCancerInternal medicineReceptorLung Cancer Treatments and MutationsQuinazolinone synthesis and applicationsCancer therapeutics and mechanisms
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies | Litcius